204 related articles for article (PubMed ID: 2364524)
1. Clinical features of amiodarone-induced pulmonary toxicity.
Dusman RE; Stanton MS; Miles WM; Klein LS; Zipes DP; Fineberg NS; Heger JJ
Circulation; 1990 Jul; 82(1):51-9. PubMed ID: 2364524
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
Yamada Y; Shiga T; Matsuda N; Hagiwara N; Kasanuki H
Circ J; 2007 Oct; 71(10):1610-6. PubMed ID: 17895560
[TBL] [Abstract][Full Text] [Related]
3. Gallium lung scintigraphy in amiodarone pulmonary toxicity.
Zhu YY; Botvinick E; Dae M; Golden J; Hattner R; Scheinman M
Chest; 1988 Jun; 93(6):1126-31. PubMed ID: 3371091
[TBL] [Abstract][Full Text] [Related]
4. Serial pulmonary function tests in patients treated with low-dose amiodarone.
Ulrik CS; Backer V; Aldershvile J; Pietersen AH
Am Heart J; 1992 Jun; 123(6):1550-4. PubMed ID: 1595534
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests.
Magro SA; Lawrence EC; Wheeler SH; Krafchek J; Lin HT; Wyndham CR
J Am Coll Cardiol; 1988 Sep; 12(3):781-8. PubMed ID: 3403839
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone pulmonary toxicity: a multidisciplinary review of current status.
Fraire AE; Guntupalli KK; Greenberg SD; Cartwright J; Chasen MH
South Med J; 1993 Jan; 86(1):67-77. PubMed ID: 8420020
[TBL] [Abstract][Full Text] [Related]
7. Serial lung function testing in patients treated with amiodarone: a prospective study.
Gleadhill IC; Wise RA; Schonfeld SA; Scott PP; Guarnieri T; Levine JH; Griffith LS; Veltri EP
Am J Med; 1989 Jan; 86(1):4-10. PubMed ID: 2910095
[TBL] [Abstract][Full Text] [Related]
8. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
Ulrik CS; Aldershvile J
Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of amiodarone pulmonary toxicity.
Kudenchuk PJ; Pierson DJ; Greene HL; Graham EL; Sears GK; Trobaugh GB
Chest; 1984 Oct; 86(4):541-8. PubMed ID: 6478892
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance.
Sunderji R; Kanji Z; Gin K
Can J Cardiol; 2000 Nov; 16(11):1435-40. PubMed ID: 11109040
[TBL] [Abstract][Full Text] [Related]
11. Relationships between amiodarone dosage, drug concentrations, and adverse side effects.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):931-5. PubMed ID: 6613839
[TBL] [Abstract][Full Text] [Related]
12. [Amiodarone pulmonary toxicity].
Reĭngardene DI; Azaravichene AP; Korobkova IZ
Vestn Rentgenol Radiol; 2002; (1):43-7. PubMed ID: 12715450
[No Abstract] [Full Text] [Related]
13. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.
Devine PL; Siebert WJ; Morton SL; Scells B; Quin RJ; Heddle WF; Zimmerman PV; Donohoe PJ
Dis Markers; 1998 Nov; 14(3):169-75. PubMed ID: 10427477
[TBL] [Abstract][Full Text] [Related]
14. [Late postoperative amiodarone pulmonary toxicity].
Alonso-Fernández A; Alvarez-Sala R; Mediano O; Torres I; Moreno I
An Med Interna; 2003 Aug; 20(8):419-20. PubMed ID: 14516264
[TBL] [Abstract][Full Text] [Related]
15. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
16. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.
Pollak PT; Sharma AD; Carruthers SG
Am J Cardiol; 1990 May; 65(18):1185-91. PubMed ID: 2337027
[TBL] [Abstract][Full Text] [Related]
17. Lung disease caused by amiodarone, a new antiarrythmic agent.
Gefter WB; Epstein DM; Pietra GG; Miller WT
Radiology; 1983 May; 147(2):339-44. PubMed ID: 6836114
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone pulmonary toxicity: clinical and subclinical features.
Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of serial pulmonary function testing as an indicator of amiodarone toxicity.
Ohar JA; Jackson F; Redd RM; Evans GR; Bedrossian CW
Am J Cardiol; 1989 Dec; 64(19):1322-6. PubMed ID: 2589198
[TBL] [Abstract][Full Text] [Related]
20. Drug induced lung disease--amiodarone in focus.
Vasić NR; Milenković BA; Pešut DP; Stević RS; Jovanović DM
Med Pregl; 2014; 67(9-10):334-7. PubMed ID: 25546981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
